Apollo Endosurgery, Inc. (NASDAQ:APEN)
Industry: Healthcare

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands; and Orbera Coach, a digital and remotely delivered aftercare program. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

Current Quote*
Last: $1.950
Change: -0.130
Book: $Unk
Volume: 3,601

As Of: 05/29 13:02 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol APEN

  • No BuyIns.Net Alerts Available for APEN

Graphs for APEN


3 Month Graph


6 Month Graph


1 Year Graph